mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.7 |